Abstract
COVID-19, the coronavirus disease 2019; SARS-CoV-2, the coronavirus 2; ACE2, angiotensin converting enzyme 2; S protein, spiked glycoprotein; TMPRSS2, transmembrane serine protease 2; WHO, World Health Organization.Purpose: Although the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2, has been viably controlled in China, a new normal in healthcare strategies has become standard in China and worldwide. We conducted a questionnaire study to disseminate the experience from China in terms of urology outpatient prevention and control measures under standardized prevention policies against COVID-19.Participants and Methods: From May 3, 2020 to June 25, 2020, we conducted an anonymous cross-sectional questionnaire study, focused on the status of and experiences with outpatient urology prevention and control measures during the COVID-19 pandemic. The targeted respondents were urologists in mainland China, covering all levels of hospitals and clinics.Results: A total of 216 (97%) valid responses were collected. We found that 183 (85%) respondents were from outside of Hubei province in China. One-hundred-and-fifty-eight (73%) respondents believed that SARS-CoV-2 could be detected in urine, and that protection against urine exposure was needed. Over 80% of respondents recommended WeChat application or similar online video meetings for virtual outpatient consultations. The suggested flowcharts and recommendations to prevent new cases were easy to understand and approved by most physicians, which could provide reference for outpatient prevention and control. We still need to make adequate preparations under the new normal of the COVID-19 Epidemic, especially for those suspected of being infected.Conclusions: Although the scientific validation of the questionnaire is limited, it provides a first snapshot of the experiences relating to the prevention and control measures in urology clinics in China, and can inform future policies in this field.
Highlights
The coronavirus disease 2019 (COVID-19) began at the end of 2019 and has rapidly become an ongoing global pandemic
SARS-CoV-2 is detectable in urine, as it becomes concentrated in the urinary system and in fecal matter, remaining positive in the excretion of some patients who have recovered from COVID-19 [7]
Most respondents indicated that they believed that SARS-CoV-2 could be detected in urine, while only some believed that SARSCoV-2 was detectable in semen (Table 2.1.1,2.1.2)
Summary
The coronavirus disease 2019 (COVID-19) began at the end of 2019 and has rapidly become an ongoing global pandemic. COVID-19 prevention and control measures have become standard in Chinese healthcare providers practice due to the difficult situation of both an ongoing global pandemic and sporadic domestic epidemics. A global survey on the impact of COVID-19 on urological services showed that 41% of respondents reported that their hospital staff had been diagnosed with COVID-19 infection [2]. To this end, we conducted a national questionnaire survey to disseminate the Chinese urology outpatient experience with prevention and control measures under the new normality of COVID-19. We hope our results and experiences can help guide our future outpatient work, and can help international counterparts with anti-COVID-19 efforts in urological outpatient practice
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
